Figures
Abstract
Background
As one of the least studied bone morphogenetic proteins (BMPs), BMP9 is one of the most osteogenic BMPs. Retinoic acid (RA) signaling is known to play an important role in development, differentiation and bone metabolism. In this study, we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of mesenchymal progenitor cells (MPCs).
Methodology/Principal Findings
Both primary MPCs and MPC line are used for BMP9 and RA stimulation. Recombinant adenoviruses are used to deliver BMP9, RARα and RXRα into MPCs. The in vitro osteogenic differentiation is monitored by determining the early and late osteogenic markers and matrix mineralization. Mouse perinatal limb explants and in vivo MPC implantation experiments are carried out to assess bone formation. We find that both 9CRA and ATRA effectively induce early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as osteopontin (OPN) and osteocalcin (OC). BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Using mouse perinatal limb explants, we find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at growth plate. Progenitor cell implantation studies reveal that co-expression of BMP9 and RXRα or RARα significantly increases trabecular bone and osteoid matrix formation.
Conclusion/Significance
Our results strongly suggest that retinoid signaling may synergize with BMP9 activity in promoting osteogenic differentiation of MPCs. This knowledge should expand our understanding about how BMP9 cross-talks with other signaling pathways. Furthermore, a combination of BMP9 and retinoic acid (or its agonists) may be explored as effective bone regeneration therapeutics to treat large segmental bony defects, non-union fracture, and/or osteoporotic fracture.
Citation: Zhang W, Deng Z-L, Chen L, Zuo G-W, Luo Q, Shi Q, et al. (2010) Retinoic Acids Potentiate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells. PLoS ONE 5(7): e11917. https://doi.org/10.1371/journal.pone.0011917
Editor: Rafael Linden, Universidade Federal do Rio de Janeiro (UFRJ), Brazil
Received: April 18, 2010; Accepted: July 8, 2010; Published: July 30, 2010
Copyright: © 2010 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by research grants from the Brinson Foundation (TCH), the National Institutes of Health (CA106569, AT004418, AR50142, and AR054381 to TCH, RCH and HHL), The 863 Program of Ministry of Science and Technology of China (#2007AA2z400 to LC, TCH, ZLD), the Natural Science Foundation of China (#30901530 to XL, #30800658 to JL, and #30772211 to ZLD), and the Natural Science Foundation Project of Chongqing Science and Technology Commission #2008BB5396 (LC) and #2009BB5060 (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Mesenchymal progenitor cells (MPCs) are adherent marrow stromal cells that can self-renew [1] and differentiate into osteogenic, chondrogenic, and adipogenic lineages [2], [3], [4], [5], although MPCs have also been isolated from many tissues, such as adipose, skeletal muscle, periosteum, brain, liver, bone marrow, amniotic fluid and hair follicle [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. Osteogenesis is a sequential cascade that recapitulates most, if not all, of the cellular events occurring during embryonic skeletal development [16]. During skeletogenesis, bone formation occurs through two different pathways, intramembranous ossification or endochondral ossification [16]. Bone regeneration following a fracture progresses through sequential phases similar to endochondral ossification, starting with chemotaxis and proliferation of MPCs [2], [3], [4], [5].
Bone morphogenetic proteins (BMPs) play an important role in regulating cell proliferation and differentiation during development [5], [17], [18], [19] and have been shown to play an important role in stem cell biology [20], [21]. BMPs belong to the TGFβ superfamily and consist of at least 14 members in humans [5], [17], [18], [19], [22]. Genetic disruptions of BMPs have resulted in various skeletal and extraskeletal abnormalities during development [5], [22], [23]. BMPs fulfill their signaling activity by interacting with the heterodimeric complex of two transmembrane serine/threonine kinase receptors, BMPR type I and BMPR type II [17], [19]. The activated receptor kinases phosphorylate the transcription factors Smads 1, 5, or 8, which in turn form a heterodimeric complex with Smad4 in the nucleus and regulate the expression of target genes in concert with other co-activators [5], [17]. Upon analyzing the 14 types of BMPs, we found that BMP9 is one of the most potent BMPs in inducing osteogenic differentiation of MPCs [19], [24], [25], [26], [27], [28], [29], [30], [31]. We further demonstrated that BMP9 regulates a distinct set of downstream targets that may play a role in regulating BMP-induced osteoblast differentiation of MPCs [19], [26], [27], [28], [29], [31]. Although the functional role of BMP9 in skeletal system remains to be fully understood, its potent osteogenic activity suggests that it may be used as an efficacious bone regeneration agent. It is conceivable that other signaling molecules may act synergistically to enhance BMP9-induced bone formation.
Retinoic acids (RAs) play an important role in embryonic development and function maintenance of vital organs in adult [32], [33]. RAs regulate differentiation and metabolism by serving as ligands for two families of nuclear receptors, the RA receptors (RARα, RARα, and RARγ) that bind the abundant form of RA known as all-trans-RA (ATRA) and the retinoid X receptors (RXRα, RXRβ, and RXRγ) that bind an isomer known as 9-cis-RA (9CRA) [34], [35], normally undetectable except when vitamin A is present in excess [36]. RA binding to RAR/RXR heterodimers bound to a regulatory DNA element leads to a cascade of events resulting in recruitment of transcriptional co-activators and initiation of transcription [35], [37]. Genetic manipulations in animals have revealed that RA signaling is important for the development of the forebrain and the segmented hindbrain, and for the elongation of the body axis [32], [33], [35]. Agonists of RAR, and RXR have been shown to promote terminal differentiation of precursor cells and cancer cells [38], [39], [40], [41], [42], [43], [44]. We have recently demonstrated that RA signaling plays an important role in regulating myogenic and hepatic progenitor cell differentiation [45], [46]. Nonetheless, our current understanding of the role of RAs in adult stem cells and tissue-specific progenitors is relatively limited. In fact, it remains controversial if RA signaling promotes or inhibits chondrogenic and/or osteogenic differentiation [47], [48], [49], [50], [51], [52], [53], [54].
Here, we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of MPCs. We find that both 9CRA and ATRA effectively induce early osteogenic marker, such as alkaline phosphatase (ALP), and late osteogenic markers, such as osteopontin (OPN) and osteocalcin (OC). BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Using mouse neonatal limb explants, we find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at growth plate. Stem cell implantation studies reveal that co-expression of BMP9 and RXRα or RARα significantly increases trabecular bone and osteoid matrix formation. These results strongly suggest that RA signaling can effectively augment BMP9-induced osteogenic differentiation of MPCs.
Materials and Methods
Cell Culture and Chemicals
HEK293 and C3H10T1/2 cells were from ATCC (Manassas, VA). Cell lines were maintained in the conditions as described [24], [26], [28], [29], [30], [31], [55], [56]. All-trans retinoic acid and 9-cis retinoic acid were obtained from BIOMOL (Plymouth, PA). Retinoids were dissolved in DMSO and aliquots were stored in −80°C. DMSO was used as solvent control. For cell culture treated with retinoids, the medium was changed every 3 days. Unless indicated otherwise, all chemicals were purchased from Sigma-Aldrich or Fisher Scientific.
Recombinant Adenoviruses Expressing RFP, GFP, BMP9, RARα and RXRα
Recombinant adenoviruses were generated using AdEasy technology as described [24], [25], [30], [57], [58]. The coding regions of human BMP9, human RARα and human RXRα were PCR amplified and cloned into an adenoviral shuttle vector and subsequently used to generate recombinant adenoviruses in HEK293 cells. The resulting adenoviruses were designated as AdBMP9, AdR-RARα, and AdR-RXRα. AdBMP9 also expresses GFP, whereas AdR-RARα and AdR-RXRα express RFP as a marker for monitoring infection efficiency. Analogous adenovirus expressing only monomeric RFP (AdRFP) or GFP (AdGFP) were used as controls [27], [28], [29], [30], [31], [57], [58], [59], [60], [61].
Isolation of Mouse Embryo Fibroblasts (MEFs)
MEFs were isolated from post coitus day 13.5 mice, as previously described [29], [30], [31]. Each embryo was dissected into 10 ml sterile PBS, voided of its internal organs, and sheared through an 18-gauge syringe in the presence of 1 ml 0.25% trypsin and 1 mM EDTA. After 15 min incubation with gentle shaking at 37°C, DMEM with 10% FCS was added to inactivate trypsin. The cells were plated on 100 mm dishes and incubated for 24 hr at 37°C. Adherent cells were used as MEF cells. Aliquots were kept in a liquid nitrogen tank. All MEFs used in this study were less than five passages.
RNA Isolation and Quantitative Real-Time RT-PCR (qPCR) Analysis
Total RNA was isolated using TRIZOL Reagents (Invitrogen). Total RNA was used to generate cDNA templates by RT reaction with hexamer and Superscript II RT (Invitrogen). The first strand cDNA products were further diluted 5- to 10-fold and used as PCR templates. Quantitative real-time PCR was carried out as described [29], [30], [31], [45], [46], [55], [61], [62]. PCR primers (Table S1) were designed by using the Primer3 program to amplify the genes of interest (approximately 150–180 bp). SYBR Green-based qPCR analysis was carried out by using the Opticon DNA Engine (M J Research). The specificity of each qPCR reaction was verified by melting curve analysis and further confirmed by resolving the PCR products on 1.5% agarose gels. Ten-fold serially diluted pUC19 was used as a standard. Triplicate reactions were carried out for each sample. The cycling program was as: 94°C for 2 min for 1 cycle and 30 cycles at 92°C for 20 s, 57°C for 30 s, and 72°C for 20 s, followed by a plate read at 78°C for each cycle. All samples were run in triplicate and normalized by the endogenous expression level of GAPDH.
Alkaline Phosphatase (ALP) Assay
ALP activity was assessed by a modified Great Escape SEAP Chemiluminescence assay (BD Clontech, Mountain View, CA) and/or histochemical staining assay (using a mixture of 0.1 mg/ml napthol AS-MX phosphate and 0.6 mg/ml Fast Blue BB salt) as described [24], [25], [27], [28], [29], [30], [31], [55], [61]. For the bioluminescence assays, each assay condition was performed in triplicate and the results were repeated in at least three independent experiments. ALP activity was normalized by total cellular protein concentrations among the samples.
Transfection and Luciferase Reporter Assay
Exponentially growing cells were seeded in 25 cm2 cell culture flasks and transfected with 2 µg per flask of BMP receptor Smad-responsive luciferase reporter [63], p12xSBE-Luc or osteocalcin promoter reporter that contains 6 copies of Runx2 responsive elements, p6xOSE-Luc [64], using LipofectAmine (Invitrogen). At 16 hr after transfection, cells were replated to 24-well plates and treated with of 9-cis RA (20 µM), all-trans RA (20 µM) or solvent control. At 48 hr after treatment, cells were lysed and cell lysates were collected for luciferase assays using Promega's Luciferase Assay Kit. Each assay condition was performed in triplicate. The results were repeated in at least three independent experiments. Luciferase activity was normalized by total cellular protein concentrations among the samples. Reporter activity was expressed as mean ± S.D.
Matrix Mineralization Assay (Alizarin Red S Staining)
C3H10T1/2 cells and MEFs were seeded in 24-well cell culture plates and infected with AdGFP, AdBMP9, and/or RAs. Infected cells were cultured in the presence of ascorbic acid (50 µg/mL) and β-glycerophosphate (10 mM). At 14 days after infection, mineralized matrix nodules were stained for calcium precipitation by means of Alizarin Red S staining, as described previously [24], [25], [27], [28], [29], [30], [31], [55], [61]. Cells were fixed with 0.05% (v/v) glutaraldehyde at room temperature for 10 min. After being washed with distilled water, fixed cells were incubated with 0.4% Alizarin Red S (Sigma-Aldrich) for 5 min, followed by extensive washing with distilled water. The staining of calcium mineral deposits was recorded under bright field microscopy.
Western Blotting Analysis
Western blotting was performed as previously described [24], [25], [27], [28], [29], [30], [31], [55], [61]. Briefly, cells were collected and lysed in Laemmli buffer. Cleared total cell lysate was denatured by boiling and loaded onto a 4–20% gradient SDS–PAGE. After electrophoretic separation, proteins were transferred to an Immobilon-P membrane. Membrane was blocked with SuperBlock Blocking Buffer, and probed with the primary antibody, anti-osteopontin, anti-osteocalcin, and anti-β-actin (Santa Cruz Biotechnology, Santa Cruz, CA), followed by incubation with a secondary antibody conjugated with horseradish peroxidase. The proteins of interest were detected by using SuperSignal West Pico Chemiluminescent Substrate kit.
Subcutaneous Progenitor Cell Implantation
The reported work was conducted according to the animal care and use guidelines as stipulated in our protocol No. 71108, which was approved by the Institutional Animal Care and Use Committee of The University of Chicago. The ectopic bone formation by progenitor cell implantation was conducted as described [25], [29], [30], [31], [55]. MEFs were infected with adenoviruses as indicated (MOI = 10). At 16 hr post infection, cells were harvested, and resuspended in PBS for subcutaneous injection (5×106/injection) into the flanks of athymic nude (nu/nu) mice (5 mice per group, 4–6 week old, male, Harlan Sprague Dawley). At 4 wk after implantation, animals were sacrificed, and the implantation sites were retrieved for histologic evaluation, and other stains.
Fetal Limb Explant Culture
The skinned forelimbs of mouse embryos (E18.5) were dissected under sterile conditions and incubated in DMEM (Invitrogen) containing 0.5% bovine serum albumin (BSA, Sigma), 50 ug/ml ascorbic acid (Sigma), 1 mM β-glycerophosphate and 100 ug/ml penicillin-streptomycin (Mediatech) solution at 37°C in humidified air with 5% CO2 for up to 14 days. The limb explants were directly infected by AdBMP9 or AdGFP one day after dissection, followed by 9-cis RA (20 µM), all-trans RA (20 µM), or solvent control treatment. Medium was changed to half volume at day 7. Cultured tissues were observed in different time points under microscope to confirm the survival of tissue cells and the expression of fluorescence markers.
Histological Evaluation and Trichrome Staining
Retrieved and cultured tissues were fixed in 10% formalin (decalcified with Fisher's Cal-Ex II fixative decalcifier solution if necessary) and embedded in paraffin. Serial sections of the paraffin-embedded samples were deparaffinized, then rehydrated in a graduated fashion, and stained with hematoxylin and eosin (H & E) and Masson's Trichrome [25], [29], [30], [31], [55].
Statistical Analysis
Microsoft Excel was used to calculate standard deviations (SD) and statistically significant differences between samples using the two-tailed Student's t-test. For all quantitative assays, each assay condition was performed in triplicate and the results were repeated in at least two independent experiments. A p-value <0.05 was defined as statistically significance.
Results
Retinoic acids induce osteogenic differentiation of MPCs
There have been several conflicting reports about the role of retinoic acids in osteogenic differentiation [47], [48], [49], [50], [51], [52], [53], [54]. Here, we first tested if 9CRA and ATRA can induce osteogenic differentiation in MPCs. By treating the commonly-used MPC line C3H10T1/2 cells with 9CRA (0, 5, 10 and 20 µM), we found that the early osteogenic marker alkaline phosphatase (ALP) activity was significantly induced at as early as at day 5 (Fig. 1A). Under the similar conditions, we found that ATRA was able to effectively induce ALP activity (Fig. 1B). Interestingly, in either 9CRA or ATRA treated MPCs ALP activity peaked at day 7. However, ALP activity seemingly decreased with increased RA concentrations while the cause of this phenomenon remains to be understood. Similar results were also obtained by using MEFs (data not shown). Collectively, these results demonstrate that 9CRA and ATRA can effectively induce the early osteogenic marker ALP activity in MPCs.
(A) 9-Cis-retinoic acid (9CRA) induces ALP activity in MPCs. Subconfluent C3H10T1/2 cells were treated with varying concentrations of 9CRA or solvent control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. “*”, p<0.05; “**”, p<0.001 (vs. control groups). (B) All-trans-retinoic acid (ATRA) induces ALP activity in MPCs. C3H10T1/2 cells were treated with varying concentrations of ATRA or solvent control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. “*”, p<0.01; “**”, p<0.001 (vs. control groups).
Retinoic acids and BMP9 act synergistically in inducing ALP activity in MPCs
We next tested if retinoic acids exert any effect on BMP9-induced osteogenic differentiation. We have demonstrated that BMP9 is one of the most potent osteogenic BMPs [5], [19], [24], [25], [27], [28], [29], [30], [31], [55], [61], [65], [66]. When the AdBMP9 or AdGFP-infected MEFs were treated with different concentrations of 9CRA (0, 5, 10 and 20 µM) for 5, 7 and 9 days, we found that 9CRA was able to significantly promote BMP9-induced ALP activity mostly in a dose-dependent manner (Fig. 2A). Consistent with the synergistic effect between BMP9 and 9CRA, the ALP activity peaked on day 5, as opposed to day 7 by 9CRA alone (Fig. 2A and Fig. 1A). Likewise, we also found that ATRA was able to significantly enhance BMP9-induced ALP activity in a dose-dependent manner (Fig. 2B). In fact, a combination of BMP9 transduction and RA treatment results in up to 4-fold increase in ALP activity in MEFs. Similar results were also obtained by using C3H10T1/2 cells (data not shown). These results strongly suggest that retinoic acids and BMP9 act synergistically in promoting osteogenic differentiation in MPCs.
(A) 9CRA induces ALP activity in MPCs. Subconfluent MEFs were infected with AdBMP9 (MOI = 5) or AdGFP (MOI = 5), followed by treatment with varying concentrations of 9CRA or solvent control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. “*”, p<0.05; “**”, p<0.001 (vs. control groups). (B) ATRA induces ALP activity in MPCs. MEFs were infected with AdBMP9 (MOI = 5) or AdGFP (MOI = 5), followed by treatment with varying concentrations of ATRA or solvent control. ALP activity was measured at the indicated time points. Each assay condition was carried out in triplicate in at least two independent batches of experiments. “*”, p<0.05; “**”, p<0.001 (vs. control groups).
Retinoids potentiate BMP9-induced late osteogenic markers and matrix mineralization in MPCs
We sought to determine if retinoic acids have any effect on BMP9-induced expression of the well-established late osteogenic markers, such as osteopontin (OPN) and osteocalcin (OC) [5], [19], [24], [25], [27], [28], [29], [30], [31], [55], [61], [66]. We infected MEFs with AdBMP9 or AdGFP and then treated with 9CRA (20 µM), ATRA (20 µM), or solvent control for 7 or 9 days, and isolated the total RNA from the cells for quantitative real-time PCR (qPCR) analysis. We found that at both time points a combinations of BMP9/9CRA or BMP9/ATRA treatment resulted in a significant increase in OPN expression (p<0.05) (Fig. 3A). Likewise, we found that BMP9/9CRA or BMP9/ATRA treatment led to a significant increase in OC expression (p<0.05) (Fig. 3B). Furthermore, we conducted Western blotting experiments and confirmed that retinoic acids were able to enhance BMP9-induced OPN and OC expression at protein level (Fig. 3C). Lastly, we examined the ability of retinoic acids to potentiate BMP9-induced matrix mineralization. As shown in Fig. 3D, 9CRA and ATRA were able to augment BMP9-induced mineralization as judged by Alizarin Red S staining. Taken together, the above results strongly suggest that retinoic acids may effectively enhance both early and late stages of BMP9-induced osteogenic differentiation of MPCs.
(A) qPCR analysis of retinoic acids and BMP9 induced osteopontin (OPN) expression. Subconfluent MEFs were infected with AdBMP9 or AdGFP (i.e., -BMP9 groups, MOI = 5), and then treated with 9CRA (20 µM), ATRA (20 µM), or solvent control. At day 7 and day 9, the cells were collected for total RNA isolation. RNA was subjected to RT-PCR transcription, which was used as templates for qPCR analysis using primers specific for mouse OPN. Each assay condition was carried out in triplicate. All samples were normalized using endogenous levels of GAPDH. “*”, p<0.05; “**”, p<0.01 (vs. control groups). (B) qPCR analysis of retinoic acids and BMP9 induced osteocalcin (OC) expression. Samples prepared in (A) were used for qPCR analysis using primers specific for mouse OC. Each assay condition was carried out in triplicate. “*”, p<0.05; “**”, p<0.01 (vs. control groups). (C) Western blotting analysis of retinoic acids and BMP9 induced OPN and OC expression. MEFs were infected with AdBMP9 or AdGFP (i.e., -BMP9 groups, MOI = 5), and then treated with 9CRA (20 µM), ATRA (20 µM), or solvent control. At day 7, cells were lysed and subjected to Western blotting analysis using anti-OPN or anti-OC antibody (Santa Cruz Biotechnology). Anti-β actin antibody was used to demonstrate equal loading of all samples. (D) Retinoic acids and BMP9 induce matrix mineralization. MEFs were infected with AdBMP9 or AdGFP (i.e., -BMP9 groups, MOI = 5), and then treated with 9CRA (20 µM), ATRA (20 µM), or solvent control. At day 14, cells were subjected to Alizarin Red S staining. Experiments were carried out in duplicate and representative results are shown.
Retinoids induce BMP9 expression and activate BMPR-Smad pathway
We next sought to explore the possible mechanism behind the synergy between retinoic acids and BMP9 in osteogenic differentiation. It has been reported that retinoids may regulate BMP2 and/or BMP4 expression [67], [68], [69], [70], [71]. As BMP9 is one of the least studied BMPs until recently [5], [19], [24], [25], [27], [28], [29], [30], [31], [55], [66], the regulation of BMP9 expression is not well understood. Here, we treated MEFs with 9CRA (20 µM), ATRA (20 µM), or solvent control for 3 and 5 days. Using qPCR analysis, we found that retinoic acids were able to significantly up-regulate BMP9 expression (p<0.05) (Fig. 4A).
(A) Retinods induce BMP9 expression in MPCs. Subconfluent MEFs were treated with 9CRA (20 µM), ATRA (20 µM), or solvent control. At day 3 and day 5, the cells were collected for total RNA isolation. RNA was subjected to RT-PCR transcription, which was used as templates for qPCR analysis using primers specific for mouse BMP9. Each assay condition was carried out in triplicate. All samples were normalized using endogenous levels of GAPDH. “*”, p<0.05; “**”, p<0.01 (vs. control groups). (B) Retinods activate BMPR Smad reporter and Runx2 reporter activity in MPCs. MEFs were transfected with BMPR Smad reporter, p12xSBE-Luc or OC promoter containing Runx2-responsive element reporter, p6xOSE-Luc. The transfected cells were replated at 16h after transfection, followed by a treatment with 9CRA (20 µM), ATRA (20 µM), or solvent control. 48 h after treatment, the cells were lyzed for luciferase activity assay using Promega's Luciferase Assay kit. Each assay condition was carried out in triplicate. Luciferase activity was normalized by total cellular protein concentrations among the samples. “*”, p<0.05; “**”, p<0.001 (vs. control groups).
We further examined the effect of retinoic acids on Smad signaling and Runx2-related gene regulation. Using the BMPR Smad reporter p12xSBE-Luc [63], we found that both 9CRA and ATRA were able to enhance the BMPR Smad reporter activity by approximately 150% and 50%, respectively (p<0.05) (Fig. 4B, left panel). Likewise, 9CRA and ATRA were able to increase the osteocalcin promoter reporter activity, which contains Runx2-responsive elements and reflects Runx2-regulated osteocalcin expression [64], by approximately 150% and 100%, respectively (p<0.05) (Fig. 4B, right panel). Collectively, these results suggest that retinoic acids may exert synergistic effect at least in part through up-regulation of BMP9 expression and activation of BMPR-Smad signaling axis.
Retinoids and BMP9 promote the expansion of hypertrophic chondrocyte zone in fetal limb culture
To further investigate the synergy between retinoic acids and BMP9, we conducted tissue explant experiments. Using mouse E18.5 perinatal forelimbs, we found that a combination of BMP9 transduction and retinoic acid treatment led to a significant expansion of the hypertrophic chondrocyte zone of the cultured fetal limbs (Fig. 5A and 5B). It is noteworthy that we did not observe any significant increases in the overall length of the cultured limbs. However, this may be at least in part due to the limited culture duration (e.g., <2 weeks) so that the overall ossification and limb growth were not significantly affected. Nonetheless, these organ culture experiments suggest that BMP9 and 9CRA or ATRA may act synergistically to accelerate chondrocyte hypertrophy and subsequently endochrondral bone formation.
(A) Harvest, transduction and labeling of mouse E18.5 forelimbs (n = 5 each group). E18.5 forelimbs were dissected, and the skin was removed with the soft tissues attached. Recombinant adenovirus (5×10∧10 pfu in 1 ml medium) expressing AdGFP or AdBMP9 added to culture medium, with or without 9CRA (20 µM) or ATRA (20 µM). After two weeks, the cultured limbs were harvested, embedded, and subjected to Alizarin Red S stating. Representative low magnification images are shown. (B) Histologic evaluation. The above samples were subjected to sectioning and H & E staining, and recorded under bright field with 400× magnification. The approximate lengths of hypertrophic zones were indicated. Representative images are shown. HC, hypertrophic chondrocyte zone.
Overexpression of retinoic acid receptors enhance BMP9-induced ectopic bone formation from MPCs
Lastly, we sought to test the effect of retinoids on BMP9-induced de novo ectopic bone formation from MPCs. We have demonstrated that ectopic bone formation by stem cell implantation is a reliable and effective approach [25], [29], [30], [31]. In order to avoid the challenging deliveries of 9CRA and ATRA for in vivo studies, we have recently constructed adenoviral vectors expressing RARα and RXRα receptors, and demonstrated that they are constitutively active in a ligand-independent fashion when they are over-expressed [44], [45], [46].
We co-infected MEFs with AdBMP9 and AdR-RARα, AdRXRα, or AdRFP control and implanted the cells subcutaneously in the flanks of athymic nude mice for four weeks. Although we did not observe any significant differences in the overall sizes of bony masses among the groups, histologic analysis of the retrieved bone masses indicated that the trabecular bone and osteoid matrix areas increased significantly in BMP9/RXRα and BMP9/RARα-transduced groups (p<0.05) (Figs. 6A and 6B). It is noteworthy that AdRFP alone, AdRFP/AdR-RXRα and AdRFP/AdR-RARα groups did not form any discernable bone masses. Using Masson's Trichrome staining, we further analyzed the difference in trabecular bone and osteoid areas among the groups, and found that BMP9/RXRα and BMP9/RARα-transduced groups exhibited a significant increase in trabecular bone and osteoid areas (p<0.01) (Figs. 6C and 6D). These in vivo results strongly suggest that retinoid signaling may synergize with BMP9 activity in promoting osteogenic differentiation of MPCs.
(A) Histological evaluation of ectopic bone formation. Subconfluent MEFs were co-infected with AdBMP9 and AdRFP, AdR-RXRα, or AdR-RARα adenoviruses (MOI = 10) for 16 h. The infected cells were implanted subcutaneously (5×106/injection) into the flanks of athymic nude (nu/nu) mice (5 mice/group, 4–6 week old, male, Harlan Sprague Dawley). At 4 wk after implantation, animals were sacrificed, and the implantation sites were retrieved, fixed and decalcified. The paraffin-embedded sections were subjected to H & E staining. Representative images are shown. BM, bone matrix (ossified and osteoid); Ob, osteoblast. (B) Quantitative analysis of trabecular and osteoid matrix area. The average trabecular bone and osteoid matrix areas were determined. At least 10 samples (with ×100 magnification) from each group were randomly selected and analyzed by using ImageJ software. “*” p<0.05, “**” p<0.001. (C) Masson's Trichrome staining of ectopic bone masses. Tissue sections prepared in were subjected to Masson's Trichrome staining. Representative images are shown. Magnification, ×400. (D) Quantitative analysis of % trabecular/osteoid area over total area was done by using ImageJ. At least 10 samples (with ×100 magnification) from each group were randomly selected and analyzed. “*” p<0.01.
Discussion
We have demonstrated that BMP9 is one of the most potent osteogenic BMPs [19], [24], [25], [26], [27], [28], [29], [30], [31]. Yet BMP9 remains as one of the least studied BMPs. BMP9 (also known as growth differentiation factor 2, or GDF-2) was first identified in developing mouse liver [72], and its possible roles include inducing and maintaining the cholinergic phenotype of embryonic basal forebrain cholinergic neurons [73], inhibiting hepatic glucose production and inducing the expression of key enzymes of lipid metabolism [74], and stimulating murine hepcidin 1 expression [75]. Although the functional role of BMP9 in skeletal system remains to be fully understood, its potent osteogenic activity suggests that it may be used as an efficacious bone regeneration agent. It is conceivable that other signaling molecules may act synergistically to enhance BMP9-induced bone formation.
In this report we investigate the effect of RA signaling on BMP9-induced osteogenic differentiation of MPCs. We find that both 9CRA and ATRA effectively induce early osteogenic marker and late osteogenic markers. BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by 9CRA and ATRA in vitro. 9CRA and ATRA are shown to induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Using mouse perinatal limb explants, we find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at growth plate. Stem cell implantation studies reveal that co-expression of BMP9 and RXRα or RARα significantly increases trabecular bone and osteoid matrix formation. These results strongly suggest that RA signaling can effectively augment BMP9-induced osteogenic differentiation of MPCs.
Retinoids play an important role in embryonic development and function maintenance of vital organs in adult [32], [33]. Retinoic acid is formed solely from retinaldehyde (Rald), which is derived from vitamin A. The metabolism of vitamin A and the diverse effects of its metabolites are tightly controlled by distinct retinoid-generating enzymes, retinoid-binding proteins and retinoid-activated nuclear receptors [32], [76]. RA regulates differentiation and metabolism by serving as a ligand for two families of nuclear receptors RARs that bind the abundant form of RA known as ATRA, and the RXRs that bind an isomer known as 9CRA [34], [35], normally undetectable except when vitamin A is present in excess [36]. RXR forms heterodimers with RAR and several other nuclear receptors when bound to DNA, suggesting that RXR may function as a scaffold protein to facilitate DNA binding for several types of nuclear receptors [34], [35]. In vivo studies have demonstrated that ligand binding to just the RAR portion of RAR/RXR heterodimers is sufficient and necessary to rescue a lethal defect in RA synthesis, whereas ligand binding to RXR does not rescue the defect and is unnecessary [36]. RA-induced transcriptional activity is tightly regulated by nuclear co-repressors (NCORs) and nuclear receptor co-activators (NCOAs) [77]. Genetic manipulations in animals have revealed that RA signaling is important for the development of the forebrain and the segmented hindbrain, and for the elongation of the body axis [32], [33], [35]. RA signaling has also been implicated in early heart patterning, forelimb induction, pancreas induction, lung induction, eye formation, and some aspects of genitourinary tract development [32], [33], [78]. However, our current understanding of the role of RA in adult stem cells, and tissue-specific progenitors is relatively limited.
While conflicting results have been reported about RA's role in BMP-induced osteogenic differentiation, it is well established that RA plays an important role in differentiation and bone metabolism. Rogers et al showed that BMP2 and BMP4 were involved in the retinoic acid-induced differentiation of embryonal carcinoma cells [70]. Targeted disruption of RARα and RARγ resulted in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism [67]. BMP2 and RA signaling may cooperate to stimulate cell proliferation, repress adipogenesis, and promote osteoblast differentiation of preadipocytes [53]. Retinoic acid stimulated chondrocyte differentiation and enhanced BMP2 effects through induction of Smad1 and Smad5 [69]. Cowan et al demonstrated that BMP2 and RA accelerate in vivo bone formation, osteoclast recruitment, and bone turnover [51]. Using mouse adipose-derived adult stromal cells, Wan et al demonstrated that osteogenic differentiation requires retinoic acid and BMP receptor type IB signaling [48]. Interestingly, Hoffman et al reported that BMP4 action in skeletogenesis involved attenuation of retinoid signaling [49]. Wang et al recently showed that ATRA inhibited osteogenic differentiation of rat bone marrow stromal cells [47]. Currently, no satisfactory explanations about the conflicting observations can be offered, although it is conceivable that the synergistic action of RA and BMP may depend on different stages of osteoblastic differentiation of MPCs. Nonetheless, we have demonstrated that RA can promote BMP9-induced osteogenic differentiation and bone formation.
It has well established that RA signaling plays an important role in chondrogenesis. Cash et al reported that overexpression of RARα in transgenic animals interfered with chondrogenesis and leads to appendicular skeletal defects [79]. Further analysis of these animals showed that expression of the transgene in chondroprogenitors maintained a prechondrogenic phenotype and prevented chondroblast differentiation [54]. However, RA has been shown to stimulate chondrocyte differentiation and enhances BMP2 effects [69]. Interestingly, both RA and BMP2 induced expression of the chondrocyte maturational marker colX in chondrocyte cultures. Though the RA effect was small, it synergistically enhanced the effect of BMP2 on colX and ALP activity [69]. BMP2 did not enhance the effects of RA on an RA-responsive reporter, but RA enhanced basal activity and synergistically enhanced BMP2 stimulation of the BMP-responsive type X collagen reporter [69]. Drissi et al showed that Runx2 stimulation by RA is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes [52]. Consistent with the above observation, it has been recently reported that retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element [50]. In our studies, we have found that BMP9 and RA act together to promote the expansion of hypertrophic chondrocyte zone in perinatal limb culture.
Mechanistically, it remains to be thoroughly investigated how RA signaling cooperates with BMP9 pathway in osteogenesis. We have shown that 9CRA and ATRA can induce BMP9 expression and activate BMPR Smad-mediated transcription activity. Li et al showed that RA did not increase the expression of the type IA BMP receptor but did markedly up-regulate the expression of Smad1 and Smad5 proteins and that inhibition of RA signaling, with the selective inhibitor AGN 193109, blocked RA-mediated induction of the Smad proteins and chondrocyte differentiation [69]. Hatakeyama et al reported that expression of BMP2 mRNA was stimulated by retinoic acid in human adenocarcinoma cell line HSG-S8 [68]. The absence of RARγ was associated with a loss of the RA-inducible expression of the collagen IV (alpha 1) and BMP2 genes [67]. Nonetheless, the molecular mechanism behind the cross-talk of RA signaling and BMP9 pathway requires further investigation.
In summary, we find that retinoids effectively induce early osteogenic marker and late osteogenic markers. BMP9-induced osteogenic differentiation and mineralization is synergistically enhanced by RA in vitro. Retinoinds are shown to induce BMP9 expression and to activate BMPR Smad-mediated transcription activity. We find that BMP9 and RAs act together to promote the expansion of hypertrophic chondrocyte zone at the growth plate of mouse perinatal limb explants. Stem cell implantation studies reveal that co-expression of BMP9 and RXRα or RARα significantly increases trabecular bone and osteoid matrix formation. These results strongly suggest that RA signaling can effectively augment BMP9-induced osteogenic differentiation of MPCs. This knowledge should expand our understanding about how BMP9 cross-talks with other signaling pathways. Furthermore, a combination of BMP9 and retinoic acid (or its agonists) may be explored as effective bone regeneration therapeutics to treat large segmental bony defects, non-union fracture, and/or osteoporotic fracture.
Acknowledgments
We thank Dr. Di Chen of University of Rochester Medical Center and Dr. Hiroyuki Kawashima of Niigata University Graduate School of Medical and Dental Sciences, Japan, for their kind provision of p12xSBE-Luc and p6xOSE-Luc reporter plasmids, respectively.
Author Contributions
Conceived and designed the experiments: ZLD QL JL XL HL HHL RCH TCH BCH. Performed the experiments: WZ LC GWZ QL QS BQZ ERW FR SHK WJ JS EH YG JLG JZZ JH YB YS KY BCH. Analyzed the data: WZ ZLD LC GWZ QS BQZ ERW FR SHK JS EH YG JLG JL JH XL YB YS HL HHL TCH BCH. Contributed reagents/materials/analysis tools: WZ ZLD LC GWZ QL QS BQZ ERW FR SHK WJ JS EH YG JLG JZZ JL JH XL YB YS KY HL RCH. Wrote the paper: ZLD ERW SHK HHL TCH BCH.
References
- 1. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324–336.
- 2. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71–74.
- 3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
- 4. Aubin JE (1998) Advances in the osteoblast lineage. Biochem Cell Biol 76: 899–910.
- 5. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, et al. (2008) Regulation of osteogenic differentiation during skeletal development. Front Biosci 13: 2001–2021.
- 6. Amoh Y, Li L, Campillo R, Kawahara K, Katsuoka K, et al. (2005) Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 102: 17734–17738.
- 7. Bjerknes M, Cheng H (2006) Intestinal epithelial stem cells and progenitors. Methods Enzymol 419: 337–383.
- 8. Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, et al. (2004) Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci U S A 101: 15772–15777.
- 9. da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204–2213.
- 10. Davis AA, Temple S (1994) A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 372: 263–266.
- 11. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338–1345.
- 12. Liu Z, Martin LJ (2004) Pluripotent fates and tissue regenerative potential of adult olfactory bulb neural stem and progenitor cells. J Neurotrauma 21: 1479–1499.
- 13. Ringe J, Leinhase I, Stich S, Loch A, Neumann K, et al. (2008) Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2: 136–146.
- 14. Sinanan AC, Hunt NP, Lewis MP (2004) Human adult craniofacial muscle-derived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells appear to contain multipotential stem cells. Biotechnol Appl Biochem 40: 25–34.
- 15. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell- based therapies. Tissue Eng 7: 211–228.
- 16. Olsen BR, Reginato AM, Wang W (2000) Bone development. Annu Rev Cell Dev Biol 16: 191–220.
- 17. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685–700.
- 18. Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296: 1646–1647.
- 19. Luu HH, Song WX, Luo X, Manning D, Luo J, et al. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25: 665–677.
- 20. Varga AC, Wrana JL (2005) The disparate role of BMP in stem cell biology. Oncogene 24: 5713–5721.
- 21. Zhang J, Li L (2005) BMP signaling and stem cell regulation. Dev Biol 284: 1–11.
- 22. Hogan BL (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10: 1580–1594.
- 23. Zhao GQ (2003) Consequences of knocking out BMP signaling in the mouse. Genesis 35: 43–56.
- 24. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, et al. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A: 1544–1552.
- 25. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, et al. (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11: 1312–1320.
- 26. Peng Y, Kang Q, Cheng H, Li X, Sun MH, et al. (2003) Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 90: 1149–1165.
- 27. Peng Y, Kang Q, Luo Q, Jiang W, Si W, et al. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 32941–32949.
- 28. Luo Q, Kang Q, Si W, Jiang W, Park JK, et al. (2004) Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells. J Biol Chem 279: 55958–55968.
- 29. Sharff KA, Song WX, Luo X, Tang N, Luo J, et al. (2009) Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells. J Biol Chem 284: 649–659.
- 30. Kang Q, Song WX, Luo Q, Tang N, Luo J, et al. (2009) A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18: 545–559.
- 31. Tang N, Song WX, Luo J, Luo X, Chen J, et al. (2009) BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med 13: 2448–2464.
- 32. Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921–931.
- 33. Niederreither K, Dolle P (2008) Retinoic acid in development: towards an integrated view. Nat Rev Genet 9: 541–553.
- 34. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866–1870.
- 35. Mark M, Ghyselinck NB, Chambon P (2006) Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46: 451–480.
- 36. Mic FA, Haselbeck RJ, Cuenca AE, Duester G (2002) Novel retinoic acid generating activities in the neural tube and heart identified by conditional rescue of Raldh2 null mutant mice. Development 129: 2271–2282.
- 37. Germain P, Iyer J, Zechel C, Gronemeyer H (2002) Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415: 187–192.
- 38. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835–839.
- 39. Park BH, Breyer B, He TC (2001) Peroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer. Curr Opin Oncol 13: 78–83.
- 40. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405: 421–424.
- 41. Murphy GJ, Holder JC (2000) PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 21: 469–474.
- 42. Freemantle SJ, Spinella MJ, Dmitrovsky E (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22: 7305–7315.
- 43. Garattini E, Gianni M, Terao M (2004) Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action. Curr Pharm Des 10: 433–448.
- 44. He BC, Chen L, Zuo GW, Zhang W, Bi Y, et al. Synergistic Antitumor Effect of the Activated PPAR{gamma} and Retinoid Receptors on Human Osteosarcoma. Clin Cancer Res.
- 45. Zhu GH, Huang J, Bi Y, Su Y, Tang Y, et al. (2009) Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 78: 195–204.
- 46. Huang J, Bi Y, Zhu GH, He Y, Su Y, et al. (2009) Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 29: 1569–1581.
- 47. Wang A, Ding X, Sheng S, Yao Z (2008) Retinoic acid inhibits osteogenic differentiation of rat bone marrow stromal cells. Biochem Biophys Res Commun 375: 435–439.
- 48. Wan DC, Shi YY, Nacamuli RP, Quarto N, Lyons KM, et al. (2006) Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci U S A 103: 12335–12340.
- 49. Hoffman LM, Garcha K, Karamboulas K, Cowan MF, Drysdale LM, et al. (2006) BMP action in skeletogenesis involves attenuation of retinoid signaling. J Cell Biol 174: 101–113.
- 50. Cohen AJ, Lassova L, Golden EB, Niu Z, Adams SL (2006) Retinoids directly activate the collagen X promoter in prehypertrophic chondrocytes through a distal retinoic acid response element. J Cell Biochem 99: 269–278.
- 51. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, et al. (2005) Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 11: 645–658.
- 52. Drissi MH, Li X, Sheu TJ, Zuscik MJ, Schwarz EM, et al. (2003) Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem 90: 1287–1298.
- 53. Skillington J, Choy L, Derynck R (2002) Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159: 135–146.
- 54. Weston AD, Rosen V, Chandraratna RA, Underhill TM (2000) Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol 148: 679–690.
- 55. Luo X, Chen J, Song WX, Tang N, Luo J, et al. (2008) Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88: 1264–1277.
- 56. Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, et al. (2002) Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 8: 1288–1294.
- 57. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509–2514.
- 58. Luo J, Deng ZL, Luo X, Tang N, Song WX, et al. (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236–1247.
- 59. He TC, Chan TA, Vogelstein B, Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335–345.
- 60. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway [see comments]. Science 281: 1509–1512.
- 61. Si W, Kang Q, Luu HH, Park JK, Luo Q, et al. (2006) CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells. Mol Cell Biol 26: 2955–2964.
- 62. Bi Y, Huang J, He Y, Zhu GH, Su Y, et al. (2009) Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 108: 295–303.
- 63. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D (2003) E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278: 27939–27944.
- 64. Yoshizawa T, Takizawa F, Iizawa F, Ishibashi O, Kawashima H, et al. (2004) Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol Cell Biol 24: 3460–3472.
- 65. Tang N, Song WX, Luo J, Haydon RC, He TC (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466: 2114–2130.
- 66. Luo J, Sun MH, Kang Q, Peng Y, Jiang W, et al. (2005) Gene therapy for bone regeneration. Curr Gene Ther 5: 167–179.
- 67. Boylan JF, Lufkin T, Achkar CC, Taneja R, Chambon P, et al. (1995) Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15: 843–851.
- 68. Hatakeyama S, Ohara-Nemoto Y, Kyakumoto S, Satoh M (1996) Retinoic acid enhances expression of bone morphogenetic protein-2 in human adenocarcinoma cell line (HSG-S8). Biochem Mol Biol Int 38: 1235–1243.
- 69. Li X, Schwarz EM, Zuscik MJ, Rosier RN, Ionescu AM, et al. (2003) Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5. Endocrinology 144: 2514–2523.
- 70. Rogers MB, Rosen V, Wozney JM, Gudas LJ (1992) Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells. Mol Biol Cell 3: 189–196.
- 71. Virdi AS, Cook LJ, Oreffo RO, Triffitt JT (1998) Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol (Noisy-le-grand) 44: 1237–1246.
- 72. Song JJ, Celeste AJ, Kong FM, Jirtle RL, Rosen V, et al. (1995) Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136: 4293–4297.
- 73. Lopez-Coviella I, Berse B, Krauss R, Thies RS, Blusztajn JK (2000) Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 289: 313–316.
- 74. Chen C, Grzegorzewski KJ, Barash S, Zhao Q, Schneider H, et al. (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol 21: 294–301.
- 75. Truksa J, Peng H, Lee P, Beutler E (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A 103: 10289–10293.
- 76. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, et al. (2007) Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13: 695–702.
- 77. Collingwood TN, Urnov FD, Wolffe AP (1999) Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol 23: 255–275.
- 78. Zaret KS (2008) Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 9: 329–340.
- 79. Cash DE, Bock CB, Schughart K, Linney E, Underhill TM (1997) Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: a modulator of chondrogenesis. J Cell Biol 136: 445–457.